Podcasts about cardiovascular division

MPR News host Angela Davis revisits expert advice from recent Wellness Wednesday shows. High blood pressure is one of the most common health risks in the U.S. and it is becoming more common among young people. It affects about fourteen percent of children and teens, according to the Centers for Disease Control and Prevention.Angela talks with two cardiologists about the dangers of untreated high blood pressure and the medications and lifestyle changes that can protect your heart. Plus, a sleep researcher talks about the link between poor sleep and dementia, and two runners share tips on starting a running habit. Guests: Dr. Jamie Lohr is a pediatric cardiologist for M Health Fairview and an associate professor of pediatrics at the University of Minnesota Medical School.Dr. Bhavadharini Ramu is an advanced heart failure cardiologist with M Health Fairview and an associate professor in the Cardiovascular Division at the University of Minnesota Medical School. Dr. Michael Howell is a professor of neurology and a sleep researcher at the University of Minnesota.  For more information about volunteering for one of Dr. Howell's research studies, go to the Pre-screening Survey or call 763-913-8367.  Dr.  Kenneth Poole is an internal medicine physician and founder and captain of the Twin Cities chapter of Black Men Run.Andrea Haus is the community and marketing manager at Mill City Running, a Twin Cities running shop that hosts running events throughout the Twin Cities. Subscribe to the MPR News with Angela Davis podcast on: Apple Podcasts, Spotify or RSS.    Use the audio player above to listen to the full conversation.     

High blood pressure is one of the most common health risks in the U.S. — and most people don't even know that they have it. It's called the “silent killer” because people with high blood pressure often have no symptoms. And yet, over time, it can lead to serious problems like heart disease, strokes and kidney failure.  New data shows that high blood pressure also is becoming more common among young people. Fourteen percent of children and teens in the country either have high blood pressure or are heading toward it, according to a Centers for Disease Control and Prevention study.MPR News host Angela Davis talks with two cardiologists about the latest research on the dangers of untreated high blood pressure and the treatments and lifestyle changes that can help protect your heart. Guests: Dr. Jamie Lohr is a pediatric cardiologist for M Health Fairview and an associate professor of pediatrics at the University of Minnesota Medical School.Dr. Bhavadharini Ramu is an advanced heart failure cardiologist with M Health Fairview and an associate professor in the Cardiovascular Division at the University of Minnesota Medical School. Subscribe to the MPR News with Angela Davis podcast on: Apple Podcasts, Spotify or RSS.     Use the audio player above to listen to the full conversation.   

In this Mayo Clinic Employee Experiences episode, you will hear Leslie, an OBGYN, and Susan, a Certified Registered Nurse Anesthetist in the Cardiovascular Division, discuss their experiences with the Healing the Emotional Lives of Peers (HELP) program. The HELP Program is an enterprise-wide peer support program for colleagues who may experience emotional impacts after involvement in stressful or traumatic work-related events. The goal of the HELP Program is to assist colleagues who have been involved in such events return to a pre-event level of performance by use of trained peer supporters across Mayo Clinic.

Full Podcast Transcript at treesmendus.com Books written by podcast host Verla Fortier:Optimize Your Heart Rate: Balance Your Mind and Body With Green Space Take Back Your Outside Mindset: Live Longer, Stress  Less, and Control Your Chronic Illness Dr. Patrycja Matusik is a physician-radiologist at University Hospital, Kraków, Poland. She completed her medicine degree and PhD at Jagiellonian University in Kraków. In her work she focuses primarily on cardiovascular imaging, lung diseases and neuroimaging.In her scientific work, one of the main directions is heart rate variability (HRV). She went to the Cardiovascular Division at the Department of Medicine at Washington University School of Medicine in St. Louis, Missouri, USA on two occasions. There she completed internships in the field of advanced methods of ECG analysis under the mentorship of Prof. Phyllis K. Stein in the Heart Rate Variability Laboratory. She is the co-author of several scientific papers published in peer-reviewed international journals, including the European Heart Journal. 1.    Please tell us a little more about your personal - why you are interested in lupus erythematosus.  First, I want to say thank you for inviting me to your podcast.As you said I'm a physician radiologist from Poland. Privately, I'm a mother of 3-year-old Julia. My husband, Paweł Matusik, is also a doctor – a cardiologist, and together we combine our passion for scientific research.  I was inspired by lupus for the first time on my internship at the Heart Rate Variability Laboratory led by Prof. Phyllis K. Stein at Washington University in St. Louis. During the course of lupus, involvement of multiple organ systems, including the cardiovascular and autonomic nervous system, occurs. Therefore, we decided to bring together and summarize current knowledge about the scientific findings and potential clinical utility of heart rate variability measures in patients with systemic lupus erythematosus. 2.     Please tell us what lupus erythematosus is and what can happen during the disease process as it relates to your publication “ Heart Rate Variability in patients with systemic lupus erythematosus: a systematic review and methodological considerations.”  Systemic lupus erythematosus is a chronicFor peer reviewed research on how your time spent in green space can change your mindset, balance your nervous system and your heart rate please go to my website https://treesmendus.com and check out my books Take Back Your Outside Mindset: Live Longer, Stress Less, and Control Your Chronic Illness and Optimize Your Heart Rate: Balance Your Mind and Body With Green Space

Welcome to Living Well with MS, the Overcoming MS podcast where we explore all topics relating to living well with multiple sclerosis (MS). In this episode, we are pleased to welcome Dr Michelle O'Donoghue, OMSer (someone following the Overcoming MS Program) and co-editor of the Overcoming Multiple Sclerosis Handbook, as our guest.  Keep reading for the key episode takeaways and Michelle's bio.   Make sure you sign up to our newsletter to hear our latest tips and news about living a full and happy life with MS. And if you're new to Overcoming MS, visit our introductory page to find out more about how we support people with MS.  Michelle's bio:  Career  Dr Michelle O'Donoghue is an Associate Professor of Medicine at Harvard Medical School and a practicing physician in the Cardiovascular Division at Brigham and Women's Hospital in Boston. She is the inaugural recipient of the McGillycuddy-Logue Distinguished Chair in Cardiology.   Dr O'Donoghue earned her medical degree at Columbia University College of Physicians and Surgeons in New York City. She subsequently completed a Master's in public health degree at the Harvard School of Public Health.   MS diagnosis and Overcoming MS  Dr O'Donoghue was diagnosed with multiple sclerosis in 2010 and adopted the Overcoming MS Program (diet and lifestyle changes) shortly thereafter. She has lived free from clinical relapses since that time.  In 2022, Dr O'Donoghue, Professor George Jelinek and Associate Professor Sandra Neate published the Overcoming Multiple Sclerosis Handbook that they co-edited together which provides an accessible overview of the Overcoming MS Program created by Professor Jelinek, including empowering community stories.   Selected Key Takeaways  Overcoming MS offers hope and a way to change the trajectory of MS   “I think that when people first get a diagnosis [of MS], they envision that it is a course towards progressive deterioration, and progressive symptoms, and then that course can't be modified. And so, for me, it was so exciting, and it gave me so much hope, to feel like there was some ability that I might have to change that trajectory and that's a big part of why I adopted the Overcoming MS plan.”  It can take time to come to terms with an MS diagnosis and it may take time to fully embrace the Overcoming MS program   “I came across Professor Jelinek's book about Overcoming MS and the first time that I read the book, it didn't initially resonate with me as much as it did when I picked it up several months later. When I look back, I think to myself, ‘why was it that I didn't initially embrace his suggestions?' I think that there are many reasons for that. One of which was, I was still just in an initial denial in general about my diagnosis and I was going through the different phases of grief really to cope with that, and my initial reaction was denial.”  Following the Overcoming MS Program will improve your overall health   “Professor Jelinek appropriately emphasizes that all elements of the program are equally important. I try to remind myself of that on a regular basis. At the end of the day, I think that [for] anyone who's considering the Overcoming MS program, I would encourage them to recognise that it's a win-win. Following a predominantly whole food plant-based diet, adopting stress management strategies, and making sure that you deal with any mental struggles that you may have, face those demons. I think it leads you to a better place overall.”  Related Links:   Read the Overcoming MS Handbook: Roadmap to Good Health: https://overcomingms.org/overcoming-multiple-sclerosis-handbook-roadmap-good-health Read the Overcoming Multiple Sclerosis book: https://overcomingms.org/resources/overcoming-multiple-sclerosis-book Find out more about Roy Swank's research on a low saturated fat diet for people with MS https://overcomingms.org/latest/swanks-paper-looking-effect-low-saturated-fat-diet-ms Don't miss out:   Subscribe to this podcast and never miss an episode. You can catch any episode of Living Well with MS here or on your favourite podcast listening app. If you like Living Well with MS, please leave a 5-star review on Apple Podcasts or wherever you tune into the show. Feel free to share your comments and suggestions for future guests and episode topics by emailing podcast@overcomingms.org.  Make sure you sign up to our newsletter to hear our latest tips and news about living a full and happy life with MS.  If you enjoy this podcast and want to support the ongoing work of Overcoming MS, you can leave a donation here. 

This episode is hosted by Dr. Feldman, Chief Medical Office at Cadence, in conversation with Dr. Benjamin Scirica, Associate Professor at Harvard Medical School and Attending Cardiologist and Director of Innovation for the Cardiovascular Division at Brigham and Women's Hospital.Their conversation focuses on:The effectiveness of remote patient monitoring platformsThe potential for clinical trials to improve utilization of guideline directed medicationsThe use of technology to expand and improve access to care for chronic diseasesFor more information on Cadence, visit https://cadence.care/

Dr. Benjamin M. Scirica is a cardiovascular medicine specialist and associate professor of medicine at Harvard Medical School (HMS). He is the director of quality initiatives at Brigham and Women's Hospital's (BWH) Cardiovascular Division and a senior investigator at the Thrombolysis and Myocardial Infarction (TIMI) Study Group, where he is director of the Electrocardiography Core Laboratory.Dr. Scirica received his medical degree from HMS. He completed an internal medicine residency and a cardiovascular disease fellowship at BWH. He also completed a research fellowship in cardiovascular disease with the TIMI Study Group at BWH and received a master's degree in public health from Harvard School of Public Health. Dr. Scirica is board certified in cardiovascular disease.His clinical and research interests include assessing novel therapeutic agents and developing electrocardiography and cardiac biomarkers. As director of quality initiatives at the Cardiovascular Division at BWH, he leads projects to improve delivery of care and inter-disciplinary communications. At the TIMI Study Group, Dr. Scirica's research focuses on improving risk stratification and cardiovascular disease treatment. He has authored over 100 peer-reviewed publications.We hope you enjoy this episode where we discuss disruptive innovations, change implementation, and teambuilding. Welcome to leading the rounds. Questions We Asked: Tell us about your NEJM article “Disruptive and Sustaining Innovation in Telemedicine: A Strategic Roadmap”?How do we build sustainable systems to use innovative technology? Have we been able to effectively evaluate telemedicine as a healthcare media? What is your company CardioCompass? What have you learned about leading diverse interprofessional teams? What are your favorite books? Quotes & Ideas: Disruption theory by Clay ChristensenThe Innovator's Dilemma Cardiocompass In order to create an innovation, you need to release a minimum viable produce and then refine and improve it based on feedback and inefficiencies“What's the job that needs to be done” As a leader, “think out loud and let people into your thought process.”“It's almost impossible to over communicate, especially virtually.” Book Suggestions: Books about Abraham Lincoln 

Jianyi “Jay” Zhang, MD, PhD, Professor and Chair, Department of Biomedical Engineering, School of Engineering, University of Alabama at Birmingham, delivers an insightful overview of his extensive education, work, and research in cardiac tissue engineering and heart-related issues in general. Dr. Zhang is an internationally recognized leader in myocardial bioenergetics, biomaterials, and stem cells for use in cardiac repair. Dr. Zhang is a tenured Professor of Medicine and of Engineering. He is the T. Michael and Gillian Goodrich Endowed Chair of Engineering Leadership, as well as the aforementioned Chair of the Department of Biomedical Engineering. Dr. Zhang talks about his background and research interests, which include, cardiac tissue engineering, NMR imaging, and heart failure. Dr. Zhang explains that myocardial bioenergetics pertains to how energy is produced in the mitochondria, transported, and utilized to generate force to pump blood. Dr. Zhang explains how the processes work, and some of the reasons why hearts fail to pump properly. The research doctor explains the energy metabolism reserve as it relates to dysfunction. He talks energy production in detail as he explains how the mitochondria can utilize glucose, fatty acid, and literally anything available. Dr. Zhang states that researchers are getting closer each day to understanding some of the complex problems of the heart, getting closer to being able to alter pathways—to utilize as a therapy method to prevent heart failure altogether or at least delay its occurrence. Dr. Zhang talks about the structure of the heart and its various components. He explains the use of gene therapy in their work, and discusses the current work and research regarding the use of patches that could possibly cure debilitating heart failure. Dr. Zhang earned his MD from Shanghai Medical University in the early 80s, and went on to earn a PhD in biomedical engineering from the University of Minnesota in 1992. In addition, Dr. Zhang holds a master of science in engineering as well as a certificate of business administration from the prestigious Tufts University in Massachusetts. Dr. Zhang completed his post-doc work at the University of Minnesota in the Cardiovascular Division.

Juan-Pablo Mas, Partner, Action Potential Venture Capital Juan-Pablo is a partner at Action Potential Venture Capital in Palo Alto, CA, and invests in companies that are pioneering bioelectronic medicines and neuromodulation technologies. Juan-Pablo was previously an investor at Lightstone Ventures and Morgenthaler Ventures, where he focused on therapeutic medical devices, mobile health, and biopharmaceutical investments. There he served as a Board Observer at various portfolio companies, including Ardian, Twelve, Holaira, Miramar Labs, Cabochon Aesthetics, SetPoint Medical, and Relievant Medsystems. Prior to investing, Juan-Pablo led efforts in R&D and Strategy in Medtronic's CardioVascular Division, including Pipeline Strategy, White-Space exploration, Business Development, and M&A integration efforts. He was named “Medtronic Inventor of The Year” in 2008, and has 30+ patents, granted or pending. Juan-Pablo also launched Effient (prasugrel) during his tenure on the Global Brand Strategy team at Eli Lilly & Co. Juan-Pablo earned an MBA from Stanford Graduate School of Business. He also conducted research in the Neurology Department at Stanford Hospital, while completing an M.S. in Electrical Engineering at Stanford University. There he worked on biometric signal processing applications such as neural-prosthetics, and EMG-driven feedback systems, and improved ICD algorithms. Juan-Pablo currently serves on the Board of Directors of the Boston-based non-profit, InnerCity Weightlifting.

In Cardiovascular Health, Jay N. Cohn MD., a renowned cardiologist describes the biological processes leading to heart and blood vessel disease. He challenges the conventional view that risk factors such as poor diet, and lack of exercise are the biggest culprits. Each of these widely-described risk factors is individually discussed and Dr. Cohn concludes that their role in affecting cardiovascular health is often overstated. He promotes a greater emphasis on an individual’s personal and largely inherited cardiovascular health by simple assessment of the function and structure of the arteries and heart. By identifying early disease likely to progress he advocates for early intervention, often with drug therapy, to slow disease progression and prevent symptoms of cardiovascular disease. He concludes that health care providers can better treat patients with medications that slow the biological processes that contribute to the development of artery and heart disease. These medications lower blood pressure and cholesterol, but their main effect is to slow progression of disease even in those whose blood pressure and cholesterol levels are not elevated. He describes a strategy for identifying and treating these early abnormalities before symptoms develop. Ultimately, early diagnosis and treatment, he argues, can contribute to better prevention and the slowing of cardiovascular disease. Jay N. Cohn, MD., is Professor of Medicine at the University of Minnesota Medical School and Director of the Rasmussen Center for Cardiovascular Disease Prevention. He was Director of the University’s Cardiovascular Division from 1974-96. He is widely recognized for his contributions to an understanding and management of hypertension, coronary artery disease, myocardial infarction and heart failure. He is the author of the scientific memoir “Saving Sam: Drugs, Race, and Discovering the Secrets of Heart Disease”.

Host: Alan S. Brown, MD, FACC, FAHA, FNLA Live from the Clinical Lipid Update of the National Lipid Association in Amelia Island, FL, host Dr. Alan Brown welcomes Dr. Robert Kloner, Vice President of Translation at Huntington Medical Research Institutes and Professor of Medicine in the Cardiovascular Division of Keck School of Medicine at the University of Southern California. Dr. Kloner discusses the cardiovascular risk factors associated with erectile dysfunction, safety and efficacy of erectile disfunction drugs, and benefits vs risks of supplementing with testosterone.

Host: Alan S. Brown, MD, FNLA Live from the Clinical Lipid Update of the National Lipid Association in Amelia Island, FL, host Dr. Alan Brown welcomes Dr. Robert Kloner, Vice President of Translation at Huntington Medical Research Institutes and Professor of Medicine in the Cardiovascular Division of Keck School of Medicine at the University of Southern California. Dr. Kloner discusses the cardiovascular risk factors associated with erectile dysfunction, safety and efficacy of erectile disfunction drugs, and benefits vs risks of supplementing with testosterone.

Host: Alan S. Brown, MD, FNLA Live from the Clinical Lipid Update of the National Lipid Association in Amelia Island, FL, host Dr. Alan Brown welcomes Dr. Robert Kloner, Vice President of Translation at Huntington Medical Research Institutes and Professor of Medicine in the Cardiovascular Division of Keck School of Medicine at the University of Southern California. Dr. Kloner discusses the cardiovascular risk factors associated with erectile dysfunction, safety and efficacy of erectile disfunction drugs, and benefits vs risks of supplementing with testosterone.

Host: Alan S. Brown, MD, FNLA Live from the Clinical Lipid Update of the National Lipid Association in Amelia Island, FL, host Dr. Alan Brown welcomes Dr. Robert Kloner, Vice President of Translation at Huntington Medical Research Institutes and Professor of Medicine in the Cardiovascular Division of Keck School of Medicine at the University of Southern California. Dr. Kloner discusses the cardiovascular risk factors associated with erectile dysfunction, safety and efficacy of erectile disfunction drugs, and benefits vs risks of supplementing with testosterone.